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Equine arteritis virus (EAV) is the prototypic member of the family Arteriviridae, which together with the Corona- and
Toroviridae constitutes the order Nidovirales. A common trait of these positive-stranded RNA viruses is the 39-coterminal
nested set of six to eight leader-containing subgenomic mRNAs which are generated by a discontinuous transcription
mechanism and from which the viral open reading frames downstream of the polymerase gene are expressed. In this study,
we investigated whether the unique gene expression strategy of the Nidovirales could be utilized to convert them into viral
expression vectors by introduction of an additional transcription unit into the EAV genome directing the synthesis of an extra
subgenomic mRNA. To this end, an expression cassette consisting of the gene for a green fluorescent protein (GFP) flanked
at its 39 end by EAV-specific transcription-regulating sequences was constructed. This genetic module was inserted into the
recently obtained mutant infectious EAV cDNA clone pBRNX1.38-5/6 (A. A. F. de Vries, et al., 2000, Virology 270, 84–97)
between the genes for the M and the GL proteins. Confocal fluorescence microscopy of BHK-21 cells electroporated with
capped RNA transcripts derived from the resulting plasmid (pBRNX1.38-5/6-GFP) demonstrated that the GFP gene was
expressed in the transfected cells, while the gradual spread of the infection through the cell monolayer showed that the
recombinant virus was replication competent. The development of the cytopathic effect was, however, much slower than in
cells that had received equivalent amounts of pBRNX1.38-5/6 RNA, indicating that the vector virus had a clear growth
disadvantage compared to its direct precursor. Immunoprecipitation analyses of proteins from metabolically labeled BHK-21
cells infected with supernatant of the transfected cultures confirmed that the recombinant virus vector was viable and
expressed viral genes as well as the GFP gene. Reverse transcription-PCR of the viral mRNAs extracted from cells infected
with the vector virus revealed that it directed the synthesis of nine instead of eight different EAV RNAs. These findings were
corroborated by hybridization analyses. Mapping of the leader-to-body junctions of the ninth mRNA indicated that the 39 part
of the GFP gene contains cryptic transcription signals which gave rise to at least five different RNA species ranging in size
from 1277 to 1439 nt [without oligo(A) tract]. Furthermore, translation of the unintended mRNA resulted in the production of
an extended version of the EAV M protein. Serial passage of the recombinant virus vector led to its gradual replacement by
viral mutants carrying deletions in the GFP gene. The reduction in viral fitness associated with the insertion of the expression
cassette into the EAV genome apparently caused genetic instability of the recombinant virus. © 2001 Academic PressKey Words: equine arteritis virus; Arteriviridae; Nidovirales; full-length cDNA clone; subgenomic mRNA; cryptic transcrip-
tion signal; viral expression vector; green fluorescent protein; genetic instability.
i
p
p
1
t
g
p
i
n
C
n
1INTRODUCTION
Equine arteritis virus (EAV) is an important equine viral
pathogen which causes reproductive and respiratory
disease in horses throughout the world (Doll et al., 1957;
Timoney and McCollum, 1993; de Vries et al., 1996). EAV
is a positive-stranded RNA virus which belongs to the
genus Arterivirus (family Arteriviridae) together with lac-
tate dehydrogenase-elevating virus of mice, porcine re-
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259productive and respiratory syndrome virus (PRRSV), and
simian hemorrhagic fever virus (SHFV). Although arteri-
viruses differ markedly from members of the family Coro-
naviridae (genera Coronavirus and Torovirus) in biophys-
cal properties, virion size, genome length, and structural
rotein composition, their polymerase polyproteins are
hylogenetically related (for a review see de Vries et al.,
997). The common ancestry of arteri-, corona-, and
oroviruses is further reflected by striking similarities in
enome organization, replication mechanism, gene ex-
ression strategy, and (site of) virus assembly (reviewed
n Snijder and Meulenberg, 1998). Accordingly, the mo-
ogeneric family Arteriviridae and the bigeneric family
oronaviridae were recently grouped together in the
ewly created virus order of the Nidovirales (Cavanagh,
997).
EAV has a diameter of 50 to 70 nm and consists of a
utatively icosahedral core surrounded by an envelope
ith small surface projections. The core particle is com-
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260 DE VRIES ET AL.posed of the unsegmented viral genomic RNA and a
single phosphorylated nucleocapsid (N) protein of 14
kDa (Hyllseth, 1973; Zeegers et al., 1976). The viral en-
velope contains at least five structural proteins which are
embedded in a lipid membrane (Hyllseth, 1973; de Vries
et al., 1992; Snijder et al., 1999). The large envelope
glycoprotein (GL) of 30 to 42 kDa and the 16-kDa ungly-
cosylated membrane (M) protein are major structural
proteins; the 25-kDa small envelope glycoprotein (GS)
and a poorly characterized third glycoprotein of 26/38
kDa are minor virion components. Finally, the 8-kDa
unglycosylated envelope (E) protein (Snijder et al., 1999)
is present in virus particles in intermediate amounts.
The linear genomic EAV RNA contains a 59 cap struc-
ture and a 39 poly(A) tail and has a length of 12,704 nt
[exclusive of the oligo(A) tract] (den Boon et al., 1991; van
Dinten et al., 1997; Glaser et al., 1999). Nine functional
open reading frames (ORFs) have been identified in the
viral genome (Fig. 1A; den Boon et al., 1991; Snijder et al.,
1999). The two largest of these ORFs (1a and 1b) occupy
the 59 three-quarters of the genomic EAV RNA and are
translated directly from the viral genome (RNA 1 in Fig.
1A); expression of ORF 1b requires a 21 ribosomal
frame shift (den Boon et al., 1991). As a result 2 multido-
main polyproteins (1a and 1ab) are synthesized, which
are proteolytically processed by three virus-encoded
proteases into 8 and 12 nonstructural proteins, respec-
tively (van Dinten et al., 1999, and references herein). The
genes for the other viral proteins (ORFs 2a, 2b, and 3
through 7; Fig. 1A) are located in the 39-terminal 3 kb of
the EAV genome and are expressed from a 39-coterminal
nested set of six leader-containing subgenomic mRNAs
(RNAs 2 through 7; Fig. 1A; de Vries et al., 1990). The
206-nt leader sequence is derived from the extreme 59
end of the viral genome and is fused to the bodies of the
subgenomic mRNAs at conserved hexanucleotide motifs
[59 UCAAC(U/C) 39] located upstream of every transcrip-
tion unit (Fig. 1A; de Vries et al., 1990; den Boon et al.,
1996). The generation of the EAV subgenomic mRNAs
involves base pairing between the UCAACU box imme-
diately downstream of the leader sequence and comple-
mentary sequence motifs on the genomic minus strand
(van Marle et al., 1999). Leader-to-body fusion in the
other arteriviruses (Chen et al., 1993; Meulenberg et al.,
1993; Meng et al., 1996; Saito et al., 1996; Godeny et al.,
1998; Nelsen et al., 1999) and in coronaviruses (for re-
views see van der Most and Spaan, 1995; Lai and Ca-
vanagh, 1997) is regulated by similar consensus se-
quences. From the few studies on arterivirus mRNA
synthesis, it appeared that not all potential leader-to-
body junction sites are used, which implies that addi-
tional factors are involved in their selection. These fac-
tors may include additional primary or secondary struc-
ture elements in the viral genome, viral and/or cellular
proteins, and other host cell components (van Marle et
al., 1999). Leader-to-body fusion has also been observedat genomic sites that slightly deviated from the transcrip-
tion consensus sequence (see e.g., Chen et al., 1993;
FIG. 1. (A) Structure of the EAV RNAs and expression of the viral
genes. RNA 1 corresponds to the EAV genomic RNA, RNAs 2 through
7 represent the viral subgenomic RNAs. The nine functional viral open
reading frames (1a, 1b, 2a, 2b, 3, 4, 5, 6, and 7) are indicated by boxes.
The black triangles below RNA 1 represent the major leader-to-body
fusion sites. The leader sequence with 59 cap structure is symbolized
by a small white bar preceded by a tiny black triangle. The translation
products of the EAV RNAs are indicated in the hatched boxes. The
glycoproteins encoded by EAV open reading frames 3 and 4 have been
provisionally denominated GP3 and GP4, respectively. (A)n, poly(A) tract;
nsp, nonstructural protein. (B) Structure of a part of the full-length EAV
cDNA clones pBRNX1.38 (top), pBRNX1.38-5/6 (middle), and
pBRNX1.38-5/6-gfp (bottom) and of the three smallest virus-specific
mRNAs specified by the viruses derived from these plasmids. The two
copies of the EAV RNA 7 leader-to-body fusion site are symbolized by
black rectangles. The sizes of the subgenomic mRNAs are indicated in
the boxes representing the leader sequence, and the binding sites for
primers A18 (1), 750 (1), 766 (2), and 768 (2) are also shown. On the
left the anticipated length of the (RT-) PCR products is given for different
primer combinations. nt, nucleotides. For an explanation of the other
symbols see above.den Boon et al., 1996; de Vries et al., 2000). In most of
these cases, extra base-pairing possibilities outside the
(261REPLICATION-COMPETENT EQUINE ARTERITIS VIRUS VECTORconserved transcription motif seem to compensate for
the mismatches occurring between leader and body se-
quences at the junction site. Furthermore, fusion of
leader and body segments can take place at different
positions within the conserved transcription motifs, re-
sulting in subgenomic RNA sequence heterogeneity.
There are even a few examples of subgenomic mRNAs
in which the actual joining of leader and body sequences
had occurred upstream of the transcription consensus
sequence [e.g., RNAs 3, 6, and 7 of the Lelystad isolate
of PRRSV (Meulenberg et al., 1993) and RNA 3 of EAV
den Boon et al., 1996)].
On the basis of extensive studies with coronaviruses,
several different models have been proposed to explain
nidovirus transcription (van der Most and Spaan, 1995;
Lai and Cavanagh, 1997). In the classical leader-primed
transcription model free leader RNAs transcribed from
the 39 end of the anti-genome serve as primers for
subgenomic mRNA synthesis also from genomic nega-
tive strands. According to another model the viral poly-
merase is differentially halted at the transcription con-
sensus sequences during negative-strand synthesis and
the nascent transcripts are relocated to the 59 end of the
genome where they acquire an anti-leader sequence.
The negative-stranded subgenomic RNAs that are pro-
duced in this way are subsequently transcribed into
plus-stranded subgenomic mRNAs. The subgenomic
mRNAs might also be generated by alternative splicing
of the viral genomic RNA or its negative-stranded com-
plement. In the latter case, the negative-stranded sub-
genomic RNAs serve as templates for subgenomic
mRNA synthesis.
As a consequence of the peculiar transcription strat-
egy, the EAV-specific intracellular RNAs are structurally
polycistronic with the exception of the smallest sub-
genomic mRNA (RNA 7). However, it is generally ac-
cepted that translation of each viral subgenomic mRNA
yields only one protein which is encoded by the first
gene downstream of the leader sequence. The viral sub-
genomic mRNAs thus seem to be functionally monocis-
tronic (Fig. 1A), e.g., translation of RNAs 5, 6, and 7 is
thought to result in the production of the GL, M, and N
proteins, respectively. The only exception to the rule
appears to be subgenomic mRNA 2, which directs the
synthesis of the E protein encoded by ORF 2a and the GS
protein specified by ORF 2b (Snijder et al., 1999).
In recent years many different groups of animal vi-
ruses have been subjected to genetic manipulation ei-
ther by homologous recombination or by direct mutagen-
esis of (cDNA copies of) their genomes. The availability
of reverse genetics systems for both DNA and RNA
viruses has created new perspectives for the use of
recombinant viruses as vaccines, expression vectors,
anti-tumor agents, gene therapy vectors, and drug deliv-
ery vehicles (Roth, 1994; Conzelmann and Meyers, 1996;
Pastoret et al., 1997; Garcı´a-Sastre, 1998; Friedmann,1999). Arteriviruses are among the virus groups whose
usefulness as a viral (expression) vector has not yet
been systematically investigated even though their
unique mode of virus replication and gene expression
potentially allows expression of multiple heterologous
genes. Furthermore, the ability of arteriviruses to cause
persistent infections may offer specific advantages in
situations in which prolonged expression of (foreign)
genetic information is required, while their restricted
host range may be a safeguard against unbridled spread
of virus recombinants into the environment. A final ad-
vantage of using arteriviruses as viral expression vectors
may be that they direct the synthesis of large amounts of
protein but have only a limited effect on host cell protein
synthesis (van Berlo et al., 1986).
In this report, a recently developed full-length cDNA
clone of EAV (Glaser et al., 1999; de Vries et al., 2000) has
been used to assess the utility of arteriviruses for the
expression of heterologous genes. Although an infec-
tious cDNA clone has also been obtained for PRRSV
(Meulenberg et al., 1998), we preferred to use EAV for
this study since it is the only arterivirus that can be
grown to high titers in vitro using a variety of established
cell lines. Our results showed that it is possible to con-
vert EAV into a replication-competent expression vector
by insertion of an extra transcription unit directing the
synthesis of a novel viral subgenomic mRNA in between
EAV ORFs 5 and 6. The recombinant virus vector was,
however, greatly impaired compared to the parental virus
and was gradually outcompeted by viral mutants that had
lost part of the expression cassette. Moreover, the intro-
duction of the expression module into the viral genome
triggered the formation of a collection of subgenomic
mRNAs that had their leader-to-body fusion sites located
in the second half of the foreign gene. The appearance of
these aberrant transcripts, which may have contributed
to the poor growth characteristics of the vector virus,
points toward a function of secondary structure elements
in arterivirus transcription.
RESULTS
Construction of a replication-competent arterivirus
vector expressing the GFP gene
Since each of the EAV gene products seems to be
required for the production of infectious virus particles
(Molenkamp et al., 2000), the number of possibilities to
develop EAV into a replication-proficient expression vec-
tor is limited. An obvious approach would be to insert
one or more expression cassettes consisting of a heter-
ologous gene flanked at its 39 end by a functional leader-
to-body junction sequence into the viral genome in be-
tween existing EAV ORFs. Theoretically, this would give
rise to replication-competent viruses expressing the for-
eign genes from additional EAV-specific subgenomic
mRNAs. Unfortunately, the overlapping arrangement of
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262 DE VRIES ET AL.the EAV genes complicates the genetic manipulation of
the viral genome. To overcome this problem, we recently
constructed infectious EAV cDNA clones in which ORFs
4 and 5 and/or ORFs 5 and 6 were separated by newly
introduced restriction endonuclease cleavage sites (de
Vries et al., 2000). A schematic drawing of the most
elevant part of construct pBRNX1.38-5/6 in which the
verlap between ORFs 5 and 6 had been removed is
hown in the middle of Fig. 1B. The unique AflII site
separating ORFs 5 and 6 was used for the insertion of an
expression cassette of 868 nt consisting of the green
fluorescent protein (GFP) gene followed by a copy of the
RNA 7 leader-to-body junction region. The GFP gene was
chosen because it yields an easily detectable product
which can be used as a marker for virus replication both
in vitro and in vivo. The RNA 7-specific transcription
signal not only comprised the hexanucleotide consensus
sequence at which leader-to-body fusion actually takes
place, but also included some flanking sequences (65 nt
at the 59 end and 50 nt at the 39 end) since it is unknown
to what extent the context of a given UCAAC(U/C) motif
contributes to its functionality. Although we first consid-
ered duplicating the RNA 6 leader-to-body fusion region
downstream of the GFP gene, we refrained from doing so
to minimize the risk of losing the foreign genetic infor-
mation by homologous recombination (Lai, 1992). In-
stead, we provided the vector virus with two copies of the
RNA 7 leader-to-body junction sequence (Fig. 1B, bot-
tom) because genetic recombination between them
would result in the elimination of the M gene and thus
give rise to a replication-deficient virus.
To test whether recombinant virus vector RNA was
infectious and could direct the synthesis of GFP, BHK-21
cells were transfected with capped in vitro transcripts
derived from plasmid pBRNX1.38-5/6-gfp. In the same
experiment, we also performed electroporations with
comparable amounts of RNA transcribed from the origi-
nal full-length EAV cDNA clone pBRNX1.38 (Fig. 1B, top;
Glaser et al., 1999) and from plasmid pBRNX1.38-5/6, in
which ORFs 5 and 6 are separated. After transfection the
cells were seeded onto glass coverslips and into culture
flasks. At regular intervals the cells were examined for
the development of cytopathic effect (cpe). The BHK-21
cells that had received pBRNX1.38 transcripts showed
extensive signs of infection already at 36 h posttransfec-
tion, whereas in the monolayers of the pBRNX1.38-5/6-
gfp RNA-transfected cells infectious foci were first de-
tected at 48 h after electroporation. In the cells that had
received pBRNX1.38-5/6 RNA, cpe occurred at an inter-
mediate pace, i.e., only few virus plaques were observed
at 36 h posttransfection. Moreover, at 72 h after electro-
poration the pBRNX1.38 and pBRNX1.38-5/6 RNA-trans-
fected cells had all detached from the plastic while the
cells that had obtained pBRNX1.38-5/6-gfp RNA still ad-
hered to the support despite their pronounced cytopa-
thology. As expected, the mock-transfected cells did not
v
dshow obvious changes during the experiment. The cells
grown on coverslips were fixed at 12, 24, 36, and 48 h
posttransfection, detergent-permeabilized, and stained
by indirect immunofluorescence labeling for the EAV GL
protein using a Cy3-conjugated secondary antibody. A
red fluorescence indicative of the presence of the GL
protein was observed in cells electroporated with either
of the three EAV transcripts but not in mock-transfected
cells. Consistent with the progression of the cytopathic
effect, the GL protein was detected first (i.e., at 12 h after
lectroporation) in the pBRNX1.38 and pBRNX1.38-5/6
NA-transfected cells and last (i.e., at 24 h posttransfec-
ion) in the cells electroporated with the pBRNX1.38-5/6-
fp transcripts. After irradiation with blue light some of
he cells that had received pBRNX1.38-5/6-gfp RNA pro-
uced a faint green fluorescence at 24 h after transfec-
ion which was apparently associated with the expres-
ion of the GFP gene as it was not observed in the other
ell cultures. At later time points posttransfection more of
he pBRNX1.38-5/6-gfp RNA-transfected cells started to
mit green light and the average intensity of the GFP
ignal increased. A typical example of the fluorescence
atterns observed in each of the four cell populations at
6 h after electroporation is shown in Fig. 2. The jux-
anuclear staining of the GL protein is consistent with the
arlier observation that in EAV-infected cells this mem-
rane protein is predominantly localized in the Golgi
omplex (van der Meer et al., 1998). As a result of its
mall size, which allows passive transport across the
uclear envelope (von Arnim et al., 1998), GFP was seen
oth in the cytoplasm and in the nucleus of the cell. The
elatively strong labeling of the latter compartment prob-
bly resulted from the efficient fixation of GFP to the
uclear matrix. The microscopical examinations further
evealed that virtually all of the pBRNX1.38-5/6-gfp RNA-
ransfected cells which stained positive for the GL protein
lso expressed the GFP gene, indicating that the expres-
ion of EAV ORFs and that of the GFP gene were not
utually exclusive.
To obtain definitive proof that the expression vector
as replication proficient, four parallel cultures of
HK-21 cells were transfected with DNA-free pBRNX1.38-
/6-gfp RNA; the supernatants were harvested at 4 days
fter electroporation and used to inoculate fresh BHK-21
ells. In the same experiment, we also infected a batch
f BHK-21 cells with the pBRNX1.38-5/6 virus and per-
ormed a mock infection. After 1 day at 37°C, the cells
noculated with the pBRNX1.38-5/6 virus all displayed
igns of infection, whereas only part of the pBRNX1.38-
/6-gfp virus-infected cells showed cytopathological
hanges and the mock-infected cells were completely
naffected. Furthermore, many of the pBRNX1.38-5/6-gfp
irus-infected cells but none of the control cells pro-
uced a green fluorescence. At 2 days after infection, a
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264 DE VRIES ET AL.pronounced cytopathic effect had also developed in the
pBRNX1.38-5/6-gfp virus-infected cells, indicating active
replication of the viral vector.
To evaluate whether the pBRNX1.38-5/6-gfp viruses
had retained the full-length GFP gene, total cytoplasmic
RNA was extracted from each cell culture at 24 h p.i. and
subjected to RT-PCR using an upstream primer [oligonu-
cleotide 750 (1)] localized in ORF 5 and a downstream
primer binding to the 59 terminus of the ORF 6 gene
[oligonucleotide 766 (2)] or of the GFP gene [oligonucle-
otide 768 (2)]. For comparison, the same primer pairs
were used to amplify the plasmids from which the viral
genomes were transcribed. As is shown in the upper left
of Fig. 3, amplification of both pBRNX1.38-5/6-gfp DNA
and RNA obtained after a single passage of the corre-
sponding virus yielded the expected PCR fragment of
1212 nt for oligonucleotides 750 (1) and 766 (2). In
addition, tiny amounts of smaller amplification products
were obtained when the analysis was performed with
RNA. As these small DNA fragments were not seen after
PCR amplification of pBRNX1.38-5/6-gfp DNA and had
different sizes and intensities depending on the specific
pBRNX1.38-5/6-gfp virus-infected culture that was ana-
lyzed, they were most likely not the result of false prim-
ing. The experiments carried out with oligonucleotides
750 (1) and 768 (2) corroborated the previous findings,
i.e., RT-PCR amplification of RNA obtained from cells
infected with either of the vector viruses yielded a single
PCR product (Fig. 3, upper right). The apparent molecular
mass of this DNA fragment matched with its anticipated
size of 344 nt, and a PCR product of the same length was
generated after PCR amplification of the pBRNX1.38-5/6-
gfp plasmid. The other templates did not yield any spe-
cific amplification products.
The pBRNX1.38-5/6-gfp virus directs the synthesis of
an additional subgenomic EAV mRNA
The previous experiments did not reveal whether the
GFP gene was expressed from a viral subgenomic
mRNA or translated directly from the viral genome. To
investigate if the pBRNX1.38-5/6-gfp virus directed the
synthesis of an additional subgenomic EAV mRNA, RT-
PCR amplifications were performed with the leader-spe-
cific oligonucleotide A18 (1) and the ORF 6-specific
oligonucleotide 766 (2). This should result in the prefer-
ential amplification of subgenomic EAV RNAs which
have their leader-to-body fusion sites located close to
and upstream of the 59 end of ORF 6. Accordingly, for the
BRNX1.38-5/6 virus, major PCR products of 364 (;RNA
) and 1206 nt (;RNA 5) were to be expected. Likewise,
T-PCR amplification of the pBRNX1.38-5/6-gfp virus-spe-
ific subgenomic mRNAs should primarily yield DNA
ragments of 379 and 1232 nt corresponding to the equiv-
lent of wild-type RNA 6 (which was designated RNA 89;
ide infra) and the conjectural GFP RNA, respectively.he lower left of Fig. 3 shows that the amplification
roducts of mRNAs 6 and 5 as well as those of RNAs 4,
, and 2 (de Vries et al., 2000) could be readily identified
for the pBRNX1.38-5/6 virus. In contrast, RT-PCR analysis
FIG. 3. RT-PCR analysis of total cytoplasmic RNA extracted from
mock-infected BHK-21 cells or from BHK-21 cells infected with
pBRNX1.38-5/6 virus (5/6) or pBRNX1.38-5/6-gfp virus (gfp1 and gfp2).
The RT-PCR products (lanes marked RNA) shown in the upper two gels
were obtained by using an upstream primer [oligonucleotide 750 (1)]
situated in ORF 5 and a downstream primer which was specific for
either the EAV M gene [oligonucleotide 766 (2)] or the GFP gene
[oligonucleotide 768 (2)]. As a consequence, RNAs which originated
from leader-to-body fusions downstream of the binding sites of oligo-
nucleotide 766 (2) or 768 (2) were not amplified. The arrangement of
EAV-specific sequences in the resulting RT-PCR products thus corre-
sponded to that in the respective viral genomes (see also Fig. 1B). As
a control, the same two primer pairs were also used for PCR amplifi-
cation of the cDNA clones from which the recombinant viruses were
derived (lanes marked DNA). The results in the lower left were obtained
with an ORF 6-specific antisense primer [766 (2)] and a leader-specific
sense primer [A18 (1)]. Using this primer pair subgenomic EAV mRNAs
which had their leader-to-body fusion sites located immediately up-
stream of oligonucleotide 766 (2) were preferentially amplified. In the
experiment shown in the lower right the antisense primer was replaced
by the GFP-specific oligonucleotide 768 (2), resulting in the selective
amplification of mRNAs carrying the GFP gene. On the right sides the
positions and sizes of marker DNA fragments (obtained by HinfI diges-
tion of pGEX-2T DNA) are indicated. The numbers on the left sides refer
to anticipated sizes of specific amplification products (see also Fig. 1B).of total cytoplasmic RNA extracted from pBRNX1.38-5/6-
gfp virus-infected cells yielded the RNA 89-specific DNA
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265REPLICATION-COMPETENT EQUINE ARTERITIS VIRUS VECTORfragment of 379 nt and a number of larger PCR products
of between 0.5 and 1.0 kb but not the 1232-nt DNA
fragment predicted for the GFP RNA or any other long
amplification products. This result could be explained in
three ways: (i) The newly introduced leader-to-body junc-
tion sequence was not functional or the GFP RNA was
transcribed in very low amounts. This possibility seemed
hard to reconcile with the intense green fluorescence
observed in pBRNX1.38-5/6-gfp virus-infected cells. (ii)
The GFP gene contained sequence elements interfering
with retrotranscription which resulted in the synthesis of
mainly short cDNA fragments. The failure to detect am-
plification products of the equivalents of wild-type RNAs
2 through 5 (which were designated RNAs 29 through 59;
ee below) in the RT-PCR samples derived from cells
nfected with the pBRNX1.38-5/6-gfp virus would be com-
atible with this hypothesis. (iii) The amplification of long
ubgenomic mRNAs including the GFP transcript was
nhibited by the presence in the RNA preparation of a
arge molar excess of smaller RT-PCR templates. The
act that the RT-PCR samples derived from cells infected
ith the pBRNX1.38-5/6-gfp virus contained multiple
hort DNA fragments in addition to the RNA 89-specific
mplification product was consistent with this idea.
We therefore performed another RT-PCR in which the
ownstream primer was replaced by the GFP gene-
pecific oligonucleotide 768 (2). Since this primer bound
lose to the 59 end of the GFP gene the chance of
issing the GFP RNA as a result of inefficient cDNA
ynthesis or preferential amplification of other templates
as greatly reduced. With the new primer combination a
NA fragment of the anticipated length (344 nt) was
mplified solely from total cytoplasmic RNA of cells that
T
Nomenclature and Anticipated Sizes
pBRNX1.38 pBRN
RNA Size (in nt) RNA
1 12,704 1
2 3,200 2
3 2,715–2,640b 3
4 2,234 4
5 1,883–1,771c 5
6 1,041 6
7 659 7
a RNAs 19 through 59 of the recombinant virus vector correspond to
and RNA 69 represents the transcript from which the GFP gene is e
b For RNA 3 of EAV Utr three leader-to-body junction sites were foun
c For RNA 5 of EAV Utr two leader-to-body junction sites were identad been infected with the pBRNX1.38-5/6-gfp virus (Fig.
, lower right). The newly introduced leader-to-body fu-sion site was thus indeed utilized for the synthesis of an
additional subgenomic mRNA which contains the GFP
gene in a favorable position for translation to occur, i.e.,
immediately downstream of the EAV leader sequence. In
addition, some larger amplification products, which most
likely correspond to RNAs 29 through 59, were obtained.
The pBRNX1.38-5/6-gfp virus directs the synthesis of
nine instead of eight EAV-specific RNAs
The DNA fragments of 0.5 to 1.0 kb obtained after
RT-PCR amplification of RNA extracted from pBRNX1.38-
5/6-gfp virus-infected cells with oligonucleotides A18 (1)
and 766 (2) suggested that cryptic leader-to-body fusion
sites might be located within the GFP gene. To address
this question, total cytoplasmic RNA extracted from
mock-infected BHK-21 cells and from BHK-21 cells in-
fected with the first passage of the parental, pBRNX1.38,
pBRNX1.38-5/6, or pBRNX1.38-5/6-gfp virus(es) was sep-
arated by agarose gel electrophoresis under denaturing
conditions and probed with the EAV-specific oligonucle-
otide 337 (2), which binds close to the extreme 39 ter-
inus of the viral genome and which should thus recog-
ize all EAV mRNAs. In a parallel experiment, oligonu-
leotide 768 (2) was used to specifically identify RNA
pecies carrying (the 59 part of) the GFP gene. Further-
ore, to facilitate interpretation of the results, the ex-
ected sizes of the mRNAs without the poly(A) tail were
alculated for each of the viruses on the basis of the
eader-to-body junction sites identified earlier (de Vries
t al., 1990, 2000; den Boon et al., 1996) (Table 1). As is
evident from Fig. 4, both probes appeared to be highly
specific as neither of them bound to any of the RNA
Virus-Encoded Subgenomic mRNAs
5/6 pBRNX1.38-5/6-gfp
Size (in nt) RNAa Size (in nt)
12,721 19 13,589
3,217 29 4,085
,732–2,657 39 3,600–3,525
2,251 49 3,119
,900–1,788 59 2,768–2,656
1,058 69 1,926
659 89 1,073
99 659
1 through 5 of EAV Utr; RNAs 89 and 99 are equivalent to RNAs 6 and
d.
en Boon et al. (1996).
de Vries et al. (2000).ABLE 1
of the
Virus
X1.38-
2
1
RNAs
xpressespecies present in mock-infected cells while oligonucle-
otide 768 (2) recognized only pBRNX1.38-5/6-gfp virus-
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266 DE VRIES ET AL.specific RNAs. After incubation with oligonucleotide 337
(2) (Fig. 4, left), the characteristic set of seven EAV-
specific intracellular mRNAs (RNAs 1 through 7; de Vries
et al., 1990) was clearly detected in the RNA preparation
rom cells infected with the parental virus. In addition,
wo bands were observed, which did not relate to any
articular viral mRNA but resulted from physical dis-
lacement by the abundant 18S and 28S ribosomal
NAs. Very similar hybridization patterns were obtained
ith the RNA samples extracted from cells infected with
he parental virus, pBRNX1.38 virus, or pBRNX1.38-5/6
irus. In contrast, the pBRNX1.38-5/6-gfp virus directed
he synthesis of nine major mRNAs (RNAs 19 through 99;
Fig. 4, left). The second largest of these RNA species
migrated only slightly faster than the 28S ribosomal RNA
and may therefore be confused with displaced material.
RNAs 19 through 69 also hybridized to oligonucleotide
768 (2) (Fig. 4, right) and thus contained the 59 part of the
GFP gene. On the basis of their electrophoretic mobili-
ties and hybridization properties we concluded that
pBRNX1.38-5/6-gfp virus RNAs 99 and 89 corresponded to
RNAs 7 and 6 of the other viruses, respectively (Table 1).
RNA 69 most likely represented the functional GFP mRNA
as it roughly comigrated with RNA 5 of the parental virus
(Table 1) and was the shortest RNA recognized by oligo-
FIG. 4. In situ hybridization analysis of total cytoplasmic RNA purified
(par), pBRNX1.38 virus (clo), pBRNX1.38-5/6 virus (5/6), or pBRNX1.38-5/6
directly from RNA-transfected BHK-21 cells and the gfp1 and gfp2 viruse
was extracted at 28 (par, clo), 40 (5/6), or 52 h p.i. (gfp1, gfp2) and sepa
incubated with oligonucleotide 337 (2), which binds close to the extrem
for the 59 part of the GFP gene. The positions of the different EAV-spe
the right sides. RNAs 19 through 59 of the pBRNX1.38-5/6-gfp virus are
NAs 89 and 99 of the vector virus correspond to RNAs 6 and 7 of the
unforeseen ninth RNA species produced by the pBRNX1.38-5/6-gfp virnucleotide 768 (2). Their apparent molecular masses
suggested that RNAs 19 through 59 were the actualcounterparts of RNAs 1 through 5. Indeed, the size dif-
ference between the five largest RNAs from both sets
appeared to be approximately 0.9 kb, which is consistent
with the length of the expression cassette. The presence
of RNA 79 was surprising as it could not be linked to any
of the known viral mRNAs. The fact that this transcript
hybridized both with oligo 337 (2) and with the leader-
specific oligonucleotide 441 (2) (data not shown) indi-
cated that it did not represent a discrete degradation
product of RNAs 19 through 69. The hybridization exper-
iment further showed that the pBRNX1.38-5/6-gfp virus-
infected BHK-21 cells contained relatively high amounts
of viral genomic RNA compared to BHK-21 cells infected
with the other viruses (Fig. 4, left).
Multiple functional leader-to-body junction sites are
located within the GFP gene
The unexpected ninth RNA species (designated RNA
79 in Fig. 4) was recognized by oligonucleotide 337 (2)
but not by oligonucleotide 768 (2), which implied that its
leader-to-body junction site was located within the GFP
gene. The size of RNA 79 further suggested that leader-
to-body fusion had taken place in the 39 half of the GFP
gene. To confirm this hypothesis total cytoplasmic RNA
mock-infected BHK-21 cells or from BHK-21 cells infected with EAV Utr
us (gfp1 and gfp2). Each of the recombinant virus stocks was prepared
derived from different transfection experiments. Total cytoplasmic RNA
a denaturing agarose gel. After being washed and dried the gel was
nd of the EAV RNAs, or with oligonucleotide 768 (2), which is specific
A species and of the 28S and 18S ribosomal RNAs are indicated on
ctional homologs of RNAs 1 through 5 of the wild-type virus. Likewise,
iruses. The RNA expressing the GFP gene is denoted RNA 69 and the
esignated RNA 79.from
-gfp vir
s were
rated in
e 39 e
cific RN
the funextracted from BHK-21 cells infected with pBRNX1.38-5/
6-gfp passage 1 virus was subjected to RT-PCR using the
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267REPLICATION-COMPETENT EQUINE ARTERITIS VIRUS VECTORleader-specific oligonucleotide A18 (1) as the upstream
primer and oligonucleotide 837 (2), which binds to the
extreme 39 end of the GFP gene, as the downstream
primer. Analysis of the RT-PCR products by agarose gel
electrophoresis revealed that five different DNA frag-
ments of between 0.3 and 0.5 kb had been generated as
well as low amounts of some larger amplification prod-
ucts. After removal of the PCR primers by gel filtration,
the DNA fragments were directly ligated into plasmid
pNoTA/T7. Recombinant plasmids were selected by re-
striction enzyme analysis and 16 constructs carrying
inserts of different sizes were subjected to nucleotide
sequence analysis. The nucleotide sequence of one of
the inserts (No. 17) did not show significant identity with
any part of the EAV genome, suggesting that host cell
RNA had served as the template for this RT-PCR frag-
ment. Two plasmids (Nos. 02 and 09) contained only 59
EAV-specific sequences probably as a result of errone-
ous attachment of the downstream primer (Fig. 5A). The
other inserts comprised both EAV leader- and GFP-spe-
cific sequences and thus represented subgenomic viral
RNAs generated by discontinuous transcription. On the
basis of their leader-to-body junction sites six different
RNA species were identified. The largest of these tran-
scripts (represented by plasmid 15) corresponded to the
regular GFP RNA, as the fusion of leader and body
sequences had occurred at the UCAACC box (located in
the 39 end of ORF 5) that is normally used to produce EAV
RNA 6 (Fig. 5A). The other mRNAs (designated RNAs 7.19
through 7.59) were the result of leader-to-body joining at
five adjacent sites located within the 39 half of the GFP
gene. The size difference between the largest and the
smallest of these RNA molecules was only 163 nt, which
explains why they were not resolved during gel electro-
phoresis (Fig. 4). As is shown in Fig. 5B, the fusion of
leader and body sequences did not occur at random
positions within the GFP gene, but required the presence
of hexanucleotide sequences similar or identical to the
UCAAC(U/C) motif involved in the production of genuine
EAV mRNAs.
RNA 79 codes for an extended version of the EAV M
protein
Translation of arteriviral mRNAs usually initiates at the
most 59-proximal AUG codon downstream of the leader-
to-body fusion site that is in a favorable context for
translation initiation to occur. Accordingly, the unin-
tended pBRNX1.38-5/6-gfp virus-specific transcripts col-
lectively denoted RNA 79 may give rise to N-terminally
truncated GFP molecules (Fig. 5C). To investigate this
possibility and to study whether the insertion of the GFP
gene and/or the duplication of the EAV RNA 7 leader-to-
body junction sequence influenced normal viral protein
synthesis, BHK-21 cells were either mock infected or
infected with the parental virus or with passage 1 of the
c
MpBRN1.38, pBRNX1.38-5/6, or pBRNX1.38-5/6-gfp virus-
(es). The m.o.i. used was approximately 2 TCID50 units
per cell for the viruses lacking heterologous genes but
was somewhat lower for the GFP-expressing viruses due
to an initial overestimation of their infectious titers. Next,
the cell cultures were metabolically labeled for 1 h with
35S-labeled amino acids at 24, 36, and 48 h p.i. and total
ysates of cells and media were prepared (de Vries et al.,
995). Aliquots of these lysates were then incubated with
polyclonal antiserum specific for GFP or with a cocktail
f antibodies directed against four of the EAV structural
roteins. As is shown in Fig. 6 (right), a polypeptide of 29
Da was immunoprecipitated with the anti-GFP serum
rom the lysates of pBRNX1.38-5/6-gfp virus-infected
ells. The molecular weight of this protein is in good
greement with the predicted size of GFP (217 amino
cids; 26.9 kDa). Moreover, as a protein of the same size
as not detected in the control samples we concluded
hat the 29-kDa polypeptide represented full-length GFP.
n addition, trace amounts of the EAV N protein were
onspecifically immunoprecipitated from the lysates of
irus-infected cell cultures as has been documented
efore (see, e.g., de Vries et al., 2000). Importantly, no
ther proteins were observed in the lower part of the gel
ncluding the dye front, which indicated that translation of
NA 79 did not yield N-terminally truncated GFP mole-
ules unless these were not recognized by the GFP-
pecific polyclonal antibodies.
The results obtained with the antibody cocktail
howed that each of the viruses that were analyzed
irected the synthesis of the N, M, GL, and GS proteins
Fig. 6, left). For the parental and pBRNX1.38 virus, the
ighest protein synthesis levels were reached 24 h after
nfection, whereas for the pBRNX1.38-5/6 virus structural
rotein production peaked at 36 h p.i. (data not shown)
nd thus clearly lagged behind. In the pBRNX1.38-5/6-gfp
irus-infected cells the highest rate of structural protein
ynthesis was observed at around 48 h p.i. Moreover, the
BRNX1.38-5/6-gfp virus appeared to produce relatively
mall amounts of the EAV GL protein compared to the
ther viruses at each of the investigated time points (data
ot shown). It should be noted, however, that the immu-
oprecipitation analysis may not have been completely
uantitative. Unexpectedly, a 22-kDa polypeptide was
etected in the lysates of pBRNX1.38-5/6-gfp virus-in-
ected cells but not in protein extracts obtained from
ells infected with the other viruses. Additional immuno-
recipitation experiments demonstrated that this protein
pecies was recognized exclusively by the EAV M-spe-
ific antibodies (data not shown). A close inspection of
he genomic region comprising the RNA 79 and 89 leader-
o-body fusion sites revealed the presence of an in-frame
UG codon 165 nt upstream of the start codon of the EAV
protein (Fig. 5C). Translation initiation at this AUG
odon would result in the synthesis of a 217-residue
-related polypeptide with a predicted molecular mass
268 DE VRIES ET AL.
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269REPLICATION-COMPETENT EQUINE ARTERITIS VIRUS VECTORof 23.7 kDa. We therefore concluded that translation of
RNA 79 yielded an N-terminally extended version of the
AV M protein. Although RNA 79 might specify additional
polypeptides these were not detected with the M- and
GFP-specific antisera.
The pBRNX1.38-5/6-gfp virus is genetically unstable
As a result of the inaccuracy of viral RNA polymerases,
the genomes of RNA viruses consist of a collection of
closely related sequences. The prevailing genomic se-
FIG. 6. Immunoprecipitation analysis of EAV structural protein syn-
thesis and of GFP gene expression in mock-infected BHK-21 cells or in
BHK-21 cells infected with EAV UTR (par), pBRNX1.38 virus (clo),
pBRNX1.38-5/6 virus (5/6), or pBRNX1.38-5/6-gfp virus (gfp1 and gfp2).
Each of the recombinant virus stocks was prepared directly from
RNA-transfected BHK-21 cells and the gfp1 and gfp2 viruses were
derived from different transfection experiments. Mock- or virus-infected
cells were pulse-labeled for 30 min with 35S-labeled amino acids at 24
(par, clo), 36 (mock, 5/6), or 48 (gfp1, gfp2) h p.i. Total lysates of cells and
media were then prepared and mixed with a cocktail of monospecific
antibodies directed against the EAV M, N, GL, and GS proteins (left) or
ith a polyclonal rabbit antiserum recognizing GFP (right). The posi-
ions of the N, M, GL, and GS proteins of EAV and of an N-terminally
extended version of the EAV M protein (M1) are indicated on the right
ide of the left panel. On the right, the protein band corresponding to
FP is marked. The numbers on the left sides indicate positions and
izes (in kDa) of 14C-labeled marker proteins analyzed in the same gel.
FIG. 5. (A) Overview of the pBRNX1.38-5/6-gfp virus-specific cDNA c
2 and 09 are colinear with the 59 end of the viral genome; the othe
mmediately upstream of or within the GFP gene. The small black tria
hite triangles correspond to leader-to-body fusion sites identified in th
pen reading frames have been given a name (GFP) or a number (1a,
f the RNA 79 subspecies. The cDNA clones used to determine the jun
or RNA 7.29; 03, 20, and 21 for RNA 7.39; 16 for RNA 7.49; and 11, 12, 18,
CAAC(U/C) box on the EAV genome, including 20 nt at its 59 an
ranscription-regulating sequences (Genome). For comparison, the lea
ase, nucleotides from the leader and genome sequences that unambig
onsensus sequence is shown at the bottom with the most common n
f the GFP gene. cDNA sequences as well as deduced amino acid se
he EAV M protein (which starts with the sequence MGAID) is encode
hat is duplicated in the extended version of the M protein (which starts with
ocated within and immediately downstream of the GFP gene are marked byquence within such a quasi-species is the product of the
permanent competition between viruses with slightly dif-
ferent genotypes. In contrast, genetically engineered vi-
ral genomes are not shaped by natural selection and
may thus give rise to viruses of relatively low fitness. As
is evident from Figs. 4 and 6, the relative expression
levels of the EAV-specific RNAs and virion proteins were
clearly altered due to the incorporation of the GFP gene
into the EAV genome. To investigate the consequences
of these changes for the fitness of the recombinant
viruses, the supernatants of two different cell cultures
transfected with pBRNX1.38-5/6-gfp RNA were passaged
three times in BHK-21 cells. After each round of virus
amplification, total cytoplasmic RNA was extracted from
these cells and subjected to RT-PCR using oligonucleo-
tides 750 (1) and 766 (2). For comparison, RNA samples
obtained from BHK-21 cells infected with different pas-
sages of the pBRNX1.38-5/6 virus were analyzed in par-
allel (Fig. 7). RT-PCR amplification of viral RNA from cells
infected with passage 1 of the GFP-expressing viruses
yielded a prominent DNA fragment of 1.2 kb. A PCR
product of identical size was obtained using pBRNX1.38-
5/6-gfp DNA as a template, which indicates the presence
of an intact GFP gene in virtually all the immediate
progeny of the vector viruses. After further passage of
the pBRNX1.38-5/6-gfp viruses, smaller RT-PCR products
became apparent in addition to the 1.2-kb DNA fragment.
In contrast, a single DNA fragment of 0.3 kb was ob-
tained for the pBRNX1.38-5/6 virus irrespective of the
viral passage number. It thus seems that the pBRNX1.38-
5/6 virus is stable, whereas the recombinant virus vector
was gradually outgrown by GFP gene deletion mutants.
Consistently, the proportion of cells coexpressing EAV
structural protein genes and the GFP gene rapidly de-
clined after serial passage (data not shown). Interest-
ingly, the sizes and relative amounts of the shorter am-
plification products differed for both series of pBRNX1.38-
5/6-gfp virus passages. We therefore concluded that
different genotypic changes can increase the fitness of
the vector viruses.
enerated by RT-PCR with primers A18 (1) and 837 (2). cDNA clones
clones are the result of leader-to-body fusion events that occurred
ymbolize authentic EAV transcription-regulating sequences, the small
lf of the GFP gene. Leader sequences are shown in gray and functional
nd 7). (B) Nucleotide sequence of the leader-to-body junction regions
equences of these EAV-specific RNAs were 13 for RNA 7.19; 06 and 19
24 for RNA 7.59. The sequences are aligned with the most 59-proximal
nd (59 Leader), and with the genomic sequences surrounding the
ody junction sequences of RNAs 69 and 89 are also included. In each
contribute to a specific sgRNA are shaded. The overall junction region
des displayed in the middle line. (C) Sequence analysis of the 39 half
s are indicated and methionine residues are boxed. Please note that
me 1 and that GFP is encoded in frame 2. The amino acid sequencelones g
r cDNA
ngles s
e 39 ha
5, 6, a
ction s
23, and
d 39 e
der-to-b
uously
ucleoti
quence
d in fraresidues MAWTS) is shaded and leader-to-body junction sequences
single and double lines, respectively.
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270 DE VRIES ET AL.DISCUSSION
In this paper we have documented the construction of
replication-competent arterivirus expressing the GFP
ene via an extra subgenomic mRNA. Although the re-
ombinant virus vector appeared to be severely impaired
ompared to wild-type EAV, it directed the synthesis of
ignificant amounts of GFP as evidenced by light micros-
opy and immunoprecipitation analysis. An unexpected
onsequence of the insertion of the GFP expression
assette into the EAV genome was the synthesis of a
eries of subgenomic mRNAs which had their leader-to-
ody fusion sites located in the 39 half of the foreign
ene. Translation of at least some of these transcripts
ielded an extended version of the EAV M protein. We
urther showed that repeated passage of the vector virus
esulted in the gradual loss of foreign gene expression
ue to the appearance of viral deletion mutants.
Recently two other studies reported the use of nidovi-
uses for the expression of foreign genes. In one study,
he nonessential gene 4 of mouse hepatitis virus (MHV;
enus Coronavirus) was replaced by the GFP gene using
omologous recombination (Fischer et al., 1997). The
ecombinant virus generated in this manner directed the
ynthesis of an MHV mRNA 4 equivalent specifying GFP
nstead of the ns4 protein. The GFP gene was, however,
oorly expressed and its product could be detected only
y Western blotting. In another study, van Dinten et al.
1997) inserted the gene for chloramphenicol acetyltrans-
FIG. 7. RT-PCR analysis of total cytoplasmic RNA extracted from
BHK-21 cells infected with pBRNX1.38-5/6 virus (5/6) or pBRNX1.38-5/
6-gfp virus (gfp1 and gfp2) of different passage number (lanes 1, 2, and
3) using an ORF 5-specific sense primer [oligonucleotide 750 (1)] and
an ORF 6-specific antisense primer [oligonucleotide 766 (2)]. In lanes
1, RNA extracted from BHK-21 cells that had been inoculated with virus
obtained from transfected cells was analyzed. To create internal stan-
dards, the same primer pair was used for the PCR amplification of
plasmids pBRNX1.38-5/6 and pBRNX1.38-5/6-gfp (DNA lanes). The num-
bers on the right refer to anticipated sizes of specific amplification
products (see also Fig. 1B). On the left the positions and sizes of
marker DNA fragments (obtained by HinfI digestion of pGEX-2T DNA)
are indicated.erase (CAT) at two different positions in the EAV ge-
ome. In the first construct, the CAT gene replaced part
t
pf ORF 2b to achieve its expression from a modified
ubgenomic mRNA 2. As a result of the concomitant
isruption of ORFs 2a and 2b the expression vector did
ot direct the synthesis of infectious progeny virus. In the
econd construct, the CAT gene was inserted immedi-
tely upstream of ORF 7 to accomplish its expression
rom subgenomic mRNA 7. Using this approach, ORF 6
as disrupted while the N gene was silenced, which
gain precluded the formation of infectious virus parti-
les. We therefore chose an alternative vector design in
hich the heterologous gene was expressed from an
dditional subgenomic mRNA without inactivating any of
he EAV genes (Fig. 1B, bottom). Consequently, the
BRNX1.38-5/6-gfp virus described in this report is the
irst example of a replication-proficient arterivirus vector.
The genome of EAV contains 12 UCAAC(U/C) motifs, 6
f which have been unambiguously shown to direct the
ynthesis of viral subgenomic mRNAs (de Vries et al.,
990; den Boon et al., 1996). The remaining UCAAC(U/C)
equences are either nonfunctional or give rise to unde-
ectably low amounts of EAV transcripts and there are no
ndications for the use of transcription signals that devi-
te from the hexanucleotide consensus sequence apart
rom those involved in the synthesis of minor species of
AV RNAs 3 and 5 (den Boon et al., 1996; de Vries et al.,
000). It thus seems surprising that the 39 half of the GFP
ene, which contains only 1 perfect UCAAC(U/C) motif,
irects the synthesis of at least 5 different subgenomic
RNAs. A similar phenomenon has been described by
ischer et al. (1997) after the replacement of gene 4 of
HV by a copy of the GFP gene. In addition to the
uthentic GFP transcript in which the joining of leader
nd body sequences had occurred at the intergenic
equence in front of gene 4, 11 RNA species that had
heir leader-to-body fusion sites located in the 39 half of
he GFP gene were found. For EAV the junction of leader
nd body sequences was observed solely at positions in
he GFP gene containing at least four of six nucleotides
f the consensus transcription signal (Fig. 5B) while for
HV the formation of the aberrant GFP-related tran-
cripts did not require a substantial similarity between
he genomic site at which leader-to-body fusion took
lace and the intergenic consensus sequence. Since the
nomalous leader-to-body fusion events occurred in a
egion of the MHV genome where the mRNA 5 consen-
us transcription signal would normally be located,
ischer et al. (1997) proposed that discontinuous tran-
cription could sometimes depend solely on the struc-
ure of the viral genome which in turn would be deter-
ined by long-range RNA–RNA and/or RNA–protein in-
eractions. Alignment of the genomes of the wild-type
nd the pBRNX1.38-5/6-gfp virus from either their 39 or
heir 59 end (Fig. 5A) indicated that a similar situation
oes not apply to EAV. We therefore favor the hypothesishat the GFP gene contains sequence elements that
romote leader-to-body fusion. Because the poly-
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271REPLICATION-COMPETENT EQUINE ARTERITIS VIRUS VECTORmerases of the distantly related arteri- and coronavi-
ruses are unlikely to recognize the same primary RNA
sequences, the signal inducing the formation of the ab-
errant transcripts probably resides in a secondary RNA
structure. The difficulty in obtaining RNA 19- through
69-specific RT-PCR fragments when using oligonucleo-
tide 766 (2) as the primer for cDNA synthesis may
indeed indicate that the 39 half of the GFP gene is highly
structured. It is thus conceivable that the anomalous
formation of subgenomic mRNAs is not a general con-
sequence of the insertion of foreign genetic information
into the EAV genome, but relates to a specific property of
the GFP gene. Further evidence for this hypothesis might
be obtained by analysis of the transcripts produced by
recombinant viruses in which other heterologous genes
have been incorporated or in which different parts of the
GFP ORF have been deleted. Interestingly, a recent study
of the effects of flanking sequences on the utilization of
a specific leader-to-body junction sequence in MHV also
pointed to an important role of RNA secondary structures
in the regulation of Nidovirales transcription (An and
Makino, 1998). Finally, the nucleotide sequence analysis
of the RT-PCR products of RNAs 7.19 and 7.59 (Fig. 5B)
demonstrated that these unforeseen transcripts had ob-
tained their entire leader-to-body junction sequence from
the GFP gene. These results are most consistent with a
model for discontinuous RNA synthesis in which the
hexanucleotide consensus sequences in the 39 part of
the viral genome serve as transcription terminators and
the nascent subgenomic negative-stranded RNA mole-
cules are translocated to the 59 end of the viral genome
where they interact with the UCAACU box upstream of
the polymerase gene thereby acquiring an anti-leader
sequence (van Marle et al., 1999). However, we cannot
exclude the possibility that the presence of GFP se-
quences at the leader-to-body fusion sites of EAV RNAs
7.19, 7.49, and 7.59 is the result of trimming of leader
transcripts attached to the genomic minus strand by a
39 3 59 nuclease activity associated with the viral tran-
scriptase (van der Most et al., 1994). In this context, it is
interesting to note that Mizutani et al. (2000) recently
obtained strong evidence for a transcription mechanism
of coronaviruses in which subgenomic mRNAs are syn-
thesized by discontinuous plus-strand synthesis involv-
ing binding of positive-stranded leader transcripts to the
various leader-to-body junction regions on the full-length
anti-genome.
Our immunoprecipitation analyses revealed that
pBRNX1.38-5/6-gfp virus-infected cells contained an ex-
tended version of the EAV M protein. The presence of
these unusual molecules most likely is a consequence of
the formation of the aberrant GFP-related mRNAs.
Whereas RNA 6 is generated by a leader-to-body fusion
event that positions the start codon of the M gene im-
mediately downstream of the leader sequence, upstream
joining of leader and body segments exposes additional
t
ainitiation codons to the translation machinery (Fig. 5C).
Several of these AUG codons are in frame with ORF 6
and are in a reasonably favorable context for translation
initiation to occur. The most 39 of the in-frame AUGs
ould give rise to a 217-aa protein with a predicted
olecular weight of 23.7 kDa, which is close to the
stimated size (22 kDa) of the extended version of the M
rotein displayed in Fig. 6. In view of the high abundance
f RNA 79 in pBRNX1.38-5/6-gfp virus-infected cells, it
ay seem surprising that the M-related fusion protein is
ynthesized in such low amounts. However, as is shown
n Fig. 5C, the ribosomes have to read through two to four
ermination signals (depending on the RNA 79 subspe-
ies) before reaching the proper start codon. Thus, un-
ess the M-related fusion protein is the unlikely result of
nternal translation initiation, its presence in pBRNX1.38-
/6-gfp virus-infected cells implies that (some of) these
top codons are poor translation terminators.
The synthesis in pBRNX1.38-5/6-gfp virus-infected
ells of an N-terminally extended version of the EAV M
rotein may provide an explanation for the poor growth
haracteristics of the recombinant virus vector. Since the
-related fusion protein contains two copies of the ORF
-specific amino acids 97 through 136 (Figs. 1B, bottom,
nd 5C) it might inhibit virion assembly or interfere with
irus infectivity through nonproductive interactions with
ther EAV components. However, given the low relative
bundance of the M-related fusion protein such effects
annot be explained by direct competition between func-
ional (i.e., wildtype) and nonfunctional (i.e., extended) M
olecules. Alternatively, genomic size constraints im-
osed by the nucleocapsid structure may account for the
ow (genetic) stability of the recombinant virus. However,
his possibility seems unlikely since insertion of the ex-
ression cassette added no more than 885 nt to the EAV
enome, while SHFV can accommodate 3 kb of addi-
ional sequence information compared to EAV by using a
ucleocapsid protein which contains only one extra
mino acid (Godeny et al., 1995). Moreover, the SHFV
enome contains three additional ORFs, in comparison
o the genomes of the other arteriviruses, which most
ikely have been acquired during a single recombination
vent that did not involve any changes to the nucleocap-
id protein gene (Godeny et al., 1998). Another reason for
he reduced fitness of the recombinant virus vector could
e that the insertion of the GFP module influenced over-
ll transcription and/or replication rates. The presence of
elatively high amounts of viral genomic RNA in
BRNX1.38-5/6-gfp virus-infected cells compared to cells
nfected with the other viruses (Fig. 4) would be consis-
ent with the idea that the insertion of the expression
assette has an effect on the ratio between genomic and
ubgenomic RNA synthesis. Finally, the introduction of
he GFP gene and a second copy of the RNA 7 leader-
o-body fusion site into the viral genome could have
ltered the relative expression levels of the EAV sub-
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272 DE VRIES ET AL.genomic mRNAs. As this would result in suboptimal
molar ratios of the EAV structural proteins it may have a
profound effect on viral fitness. Indeed, Fig. 6 suggests
that in pBRNX1.38-5/6-gfp virus-infected cells less GL
protein is present relative to the N, M, or GS protein than
n cells infected with wild-type EAV. Interestingly, from the
ame experiment it appeared that the changes to the 59
oncoding region of RNA 6 did not have a clear effect on
he relative expression level of the EAV M protein.
As comparatively little is known about the regulation of
rterivirus transcription and replication, the precise rea-
on for the observed changes in the viral RNA profile
aused by the insertion of the expression cassette is
nclear. From studies on coronaviruses it appeared that
he primary sequence of the leader-to-body junction mo-
ifs is not the only factor involved in transcriptional reg-
lation. Other factors that have been shown to influence
heir activity include: (i) the specific position in the viral
enome (Hiscox et al., 1995; van Marle et al., 1995), (ii)
he number of downstream leader-to-body fusion sites
van Marle et al., 1995; Krishnan et al., 1996), (iii) the
istance between functional leader-to-body junction se-
uences (Joo and Makino, 1995; van Marle et al., 1995),
nd (iv) the nucleotides flanking the leader-to-body fu-
ion sites (Makino and Joo, 1993; Hiscox et al., 1995;
eong et al., 1996; An and Makino, 1998). In addition,
sequence elements located at the 59 and 39 terminus of
the coronavirus genome appear to influence transcrip-
tion levels while coronavirus replication seems to be
primarily controlled by 59 and 39 end genomic sequences
(reviewed by Lai and Cavanagh, 1997). Since in arterivi-
ruses replication and transcription efficiencies may be
determined by a similarly complex interplay of signals
located at different positions on the viral genome, it will
be hard to predict the effects of any genomic alteration
on these processes.
If expression of heterologous ORFs from extra sub-
genomic mRNAs in the context of a complete genome
would turn out to be troublesome irrespective of the
genomic locus used for insertion, the number of dupli-
cated EAV-specific nucleotides, or the identity of the
foreign gene, other strategies could be pursued to con-
vert EAV into a viral expression vector. One approach
would be to incorporate heterologous genes and flank-
ing sequences encoding cleavage sites for one of the
viral proteases at suitable positions in EAV ORF 1. This
would result in the expression of the foreign genetic
information as part of the ORF replicase polyproteins and
the release of the heterologous gene product(s) during
proteolytic processing of the polyprotein precursors. Al-
ternatively, internal ribosomal entry segments could be
utilized to generate multicistronic mRNAs that direct the
synthesis of a viral protein and one or more foreign gene
products. Furthermore, heterologous sequences could
be expressed as an integral part of one or more of the
viral (structural) proteins. Indeed, we recently reportedthe successful expression of a MHV M protein-specific
nonapeptide as an integral part of the ectodomain of the
EAV M protein (de Vries et al., 2000). Another possibility
would be to replace EAV (structural protein) genes by
foreign genetic information and to provide the missing
viral polypeptides in trans by using either packaging cell
lines or (defective) helper constructs.
MATERIALS AND METHODS
Antisera, cells, and viruses
Cells were cultured in a humidified air–5% CO2 atmo-
phere. The Utrecht variant (de Vries et al., 1990) of the
ucyrus strain (Doll et al., 1957) of EAV (EAV Utr) and
ngineered mutants thereof were propagated in baby
amster kidney [BHK-21 (C-13)] cells (American Type
ulture Collection) maintained in Glasgow minimum es-
ential medium (GMEM; Gibco BRL Life Technologies)
ontaining 10% fetal bovine serum (FBS), 100 U/ml pen-
cillin, and 100 mg/ml streptomycin (GMEM–10% FBS).
Infectious titers of EAV stocks were determined by
TCID50 assays according to Hyllseth (1969) using rabbit
idney (RK-13) cells grown in Dulbecco’s modified Ea-
le’s medium (DMEM; Gibco BRL Life Technologies) with
0% FBS and the aforementioned antibiotics.
The production and characterization of rabbit anti-
eptide sera directed against the C-termini of the EAV M
nd GS proteins have been documented previously (de
Vries et al., 1992). The EAV GL-specific murine monoclo-
al antibodies (MAbs) 74D(B) and 93B were generated by
laser et al. (1995). The preparation of a rabbit antiserum
directed against an EAV N-specific bacterial fusion pro-
tein has been described elsewhere (Weiland et al., 2000).
An affinity-purified rabbit polyclonal antiserum raised
against a red-shifted variant of GFP was purchased from
Clontech.
RNA purification
Total cytoplasmic RNA was extracted from 20-cm2
(sub)confluent monolayers of mock- or EAV-infected
BHK-21 cells. To this end, the cells were washed once
with ice-cold phosphate-buffered saline (PBS) and lysed
in 500 ml of 20 mM Tris–HCl (pH 7.4)–150 mM NaCl–1
M EDTA containing 0.5% Triton X-100 and 0.5% 1,5-
aphthalenedisulfonic acid (disodium salt) at 0°C. The
ysate was centrifuged for 10 min at 2000 g and 4°C and
he postnuclear supernatant was mixed with 500 ml of 20
M Tris–HCl (pH 7.4)–150 mM NaCl–1 mM EDTA con-
aining 7 M urea and 2% sodium dodecyl sulfate (SDS).
he mixture was extracted once with an equal volume of
uffer-saturated phenol, three times with phenol:chloro-
orm:isoamyl alcohol (25:24:1; Sambrook et al., 1989), and
once with water-saturated ether at room temperature.
The RNA was precipitated by the addition of 100 ml of 3
M sodium acetate (pH 5.2) and 2.5 ml of ice-cold 96%
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273REPLICATION-COMPETENT EQUINE ARTERITIS VIRUS VECTORethanol, washed with 70% ethanol, and dissolved in 100
ml of H2O.
NA gel electrophoresis and in situ hybridization
nalysis
Gel electrophoresis of RNA under denaturing condi-
ions was carried out in a 2.2 M formaldehyde–1.5%
garose gel using 10 mM 3-(N-morpholino)propanesul-
fonic acid (sodium salt)–5 mM sodium acetate–1 mM
EDTA as electrode buffer. Before application to the gel, 6
ml of each RNA sample was mixed with 14 ml of dena-
uration buffer (10.3% formaldehyde, 69.4% formamide,
.43 electrode buffer), incubated at 70°C for 10 min, and
upplemented with 4 ml of loading buffer (15% Ficoll 400,
.3% Orange G). The gel was run for 16 h at 50 V and
oom temperature while the electrode buffer was recir-
ulated beginning 30 min after the start of the electro-
horesis. Next, the gel was dried on Whatman 3MM filter
aper, divided in two equal halves, detached from the
aper support, and prehybridized for 30 min at room
emperature in binding buffer [53 SSPE, 53 Denhardt,
0.05% SDS, 0.01% alkali-degraded yeast RNA (free acid)
(homomix I; Jay et al., 1974)]. One piece of the gel was
then incubated overnight at 55°C with 100 ng of oligo-
nucleotide 337 (2) (Table 2) in binding buffer. The other
half of the gel was probed under the same conditions
with 100 ng of oligonucleotide 768 (2) (Table 2). Before
addition to the hybridization solution, the oligonucleo-
tides were radiolabeled at their 59 ends using bacterio-
phage T4 polynucleotide kinase and [g-32P]ATP (63000
i/mmol; Amersham Pharmacia Biotech). The gel pieces
ere subsequently washed three times for 15 min at the
ybridization temperature with 53 SSPE–0.05% SDS,
overed with plastic foil, and exposed at 270°C to
T
Oligo
Namea Sequenceb Po
A18 (1) GCTCGAAGTGTGTATGGTGC
337 (2) CTTCAACATGACGCCACACAGGAG 1265
441 (2) CCGAGAGGGGCCCACAAG 6
724 (1) AGGGTACCATCGCCAACTGGTGG 1218
725 (2) AGGGTACCTTAAGCTTGTTACCAACTGCG 1229
750 (1) CGGGATCCTCCGCCAATTACTGTGGTT 1168
766 (2) CCAGATGCTACATACCTAGTA 1199
768 (2) ccctctccgctgacagaaa
837 (2) CGGAATTcacttgtacagctcgtcca
a Positive-sense primers are marked (1); negative-sense primers ar
b Nucleotides not specific for the EAV genome or the GFP gene are
c The positions of the virus-specific sequences encoded by individua
et al., 1991; van Dinten et al., 1997; Glaser et al., 1999).ioMax MS film (Eastman Kodak) sandwiched between a
ioMax TranScreen from the same company.
t
uDNA synthesis and PCR amplification
Total cytoplasmic RNA (10.5 ml) from mock- or EAV-
nfected BHK-21 cells was mixed with 1 ml of 50 mM
reverse transcription primer, incubated for 10 min at
65°C, and immediately cooled on ice. Next, 4 ml of 250
M Tris–HCl (pH 8.3 at 25°C)–200 mM KCl–25 mM
gCl2–2.5% Tween 20, 2 ml of 100 mM DTT, 0.8 ml of 25
mM each dNTP, 0.7 ml of RNAguard (33.4 U/ml; Amer-
sham Pharmacia Biotech), and 1 ml of Expand reverse
ranscriptase (50 U/ml; Boehringer Mannheim) were
added and the sample was incubated for 1 h at 42°C.
The reaction was then stopped on ice or the template
RNA was first degraded by RNase H treatment (de
Vries et al., 2000) and the sample was frozen at
20°C.
PCR amplifications were routinely performed in 50-ml
volumes using thin-walled 0.5-ml vials. A typical reaction
mixture contained 1 ng of (linearized) plasmid DNA or 0.2
to 2 ml of cDNA, 20 mM Tris–HCl (pH 8.4), 50 mM KCl, 2
mM MgCl2, 200 to 400 mM each dNTP, 500 mM both
forward and reverse primers, and 1.25 to 2.5 U of Ther-
mus aquaticus DNA polymerase (Gibco BRL Life Tech-
nologies). The samples were prepared on ice, overlaid
with 25 ml of mineral oil, and placed in a preheated
thermocycler (Perkin–Elmer) at 94°C for 2 min. The target
sequences were amplified in 25 cycles. Each round of
amplification consisted of a denaturation step at 94°C for
30 s, followed by an annealing period of 10 to 15 s at 50
to 55°C, depending on the specific primer pair used, and
an elongation step at 72°C for 1 min with an extension
period of between 0 and 3 s per cycle. The resulting DNA
fragments were analyzed in 1 to 2% agarose gels con-
taining 1 mg/ml ethidium bromide in the gel solution and
100 ng/ml intercalator in the electrode buffer. In one case,
tides
Use
Analytical PCR; PCR to amplify RNA 79 subspecies
1 Hybridization analysis
Hybridization analysis
4 PCR to amplify RNA 7 leader-to-body junction sequence
8 RT-PCR to amplify RNA 7 leader-to-body junction sequence
5 Analytical PCR
0 Analytical RT-PCR
Analytical RT-PCR; hybridization analysis
RT-PCR to amplify RNA 79 subspecies
olized by (2).
underlined, GFP-specific nucleotides are shown in lowercase.
rs are based on the complete genomic sequence of EAV Utr (den BoonABLE 2
nucleo
sitionc
1–20
8–1268
3–80
7–1220
0–1230
4–1170
0–1201
*
*
e symb
singlyhe PCR products were cloned into the pNoTA/T7 vector
sing the Prime PCR Cloner kit (5 Prime 3 3 Prime).
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274 DE VRIES ET AL.Construction of plasmid pBRNX1.38-5/6-gfp
Recombinant DNA procedures were either adopted
from Ausubel et al. (1987) or Sambrook et al. (1989) or
performed according to the instructions supplied with
specific reagents. Escherichia coli strain PC2495
(Phabagen) was used for all cloning steps and DNA was
transfected into these bacteria by high-voltage treatment
using a Gene Pulser II (Bio-Rad) electroporation appara-
tus and electroporation cuvettes with a 2-mm electrode
gap (BTX). The generation of the full-length EAV cDNA
clone pBRNX1.38 (Fig. 1B, top) and its derivative
pBRNX1.38-5/6 in which ORFs 5 and 6 are separated by
a unique AflII restriction enzyme recognition site (Fig. 1B,
middle) has been described elsewhere (de Vries et al.,
2000). To construct the EAV-based expression vector
pBRNX1.38-5/6-gfp, the “humanized” gene for a GFP vari-
ant with enhanced specific fluorescence was excised
from plasmid pGreen Lantern-1 (Gibco BRL Life Technol-
ogies) by using NotI and ligated into pUCBM20 (Boehr-
inger Mannheim). For this purpose, the cloning vector
had been digested with the same restriction endonucle-
ase and dephosphorylated with shrimp alkaline phos-
phatase (Amersham Pharmacia Biotech). Recombinant
plasmids in which the GFP gene was flanked at its 59
end by the AflII site of the vector were identified by
restriction enzyme analysis. One of these constructs
(pAVI-gfp) was incubated with KpnI and dephosphory-
lated using shrimp alkaline phosphatase. Subsequently,
a 127-nt EAV-specific PCR product containing the RNA 7
leader-to-body junction sequence in the middle was li-
gated into the KpnI-digested plasmid. The latter frag-
ment, which corresponds to nucleotide positions 12187
to 12308 of the genome of EAV Utr, was generated using
oligonucleotides 724 (1) and 725 (2) as primers (Table
2) and EAV cDNA clone PB106 (de Vries et al., 1990) as
template. Before insertion into pAVI-gfp, the amplification
product was purified from gel with the aid of the QIA-
quick gel extraction kit (Qiagen) and cut with KpnI. A
number of plasmid DNA clones were subjected to nu-
cleotide sequence analysis using a T7 DNA polymerase
sequencing kit and [a-33P]dATP ($2500 Ci/mmol; Amer-
ham Pharmacia Biotech), and one of the constructs
ontaining an intact and properly oriented copy of the
AV RNA 7 leader-to-body fusion site was incubated with
frI. This yielded an 868-nt fragment which was ligated
nto the AflII site of plasmid pAVIs5/6 (de Vries et al.,
000) to produce pAVIs5/6-gfp. In the latter vector, the
FP gene is preceded at its 59 end by the 39 terminus of
AV ORF 5 and is followed at its 39 end by the copy of the
ranscription-regulating sequence that directs EAV RNA
synthesis. Finally, pBRNX1.38-5/6-gfp was constructed
y insertion of the 1.2-kb SfiI–XbaI fragment from pAVIs5/
-gfp into SfiI- and XbaI-digested pBRNX1.38 (Fig. 1B,
ottom).NA transcription
In vitro transcription reactions were performed essen-
ially as described by Olkkonen et al. (1994) except that
(59)ppp(59)G (Amersham Pharmacia Biotech) instead of
7G(59)ppp(59)G served as cap analogue while XhoI was
sed to linearize the DNA templates. The reactions were
topped on ice, the integrity and yield of the RNA prod-
cts was determined by agarose gel electrophoresis
nder native conditions, and the samples were tran-
iently stored at 220°C. When indicated the plasmid
NA was degraded after completion of the RNA synthe-
is by a treatment for 30 min at 37°C with 1 U of RQ1
Nase-free DNase (Promega) and the nuclease was
nactivated by a 10-min incubation at 65°C.
nfection and transfection experiments
BHK-21 cells were transfected with EAV-specific RNA
and cDNA) by electroporation (Olkkonen et al., 1994).
riefly, 80-cm2 monolayers of newly confluent cells were
rypsinized, suspended in 10 ml of GMEM–10% FBS, and
elleted at 400 g for 5 min. The cells were washed in 10
l PBS without CaCl2 and MgCl2, repelleted, and resus-
pended in 800 ml PBS. One-fifth to two-fifths of the tran-
cription reaction was then added to the cell suspension
nd the mixture was transferred to electroporation cu-
ettes with a 4-mm gap size (BTX). The cells were pulsed
wice at 800 V, 25 mF and, with the pulse controller set at
nfinite, resuspended in 20 ml of GMEM–10% FBS and
eeded into 185-cm2 flasks and onto glass coverslips.
After transfection, the cells were transferred to a CO2
incubator of 37°C.
Confocal laser scanning microscopy
Mock-transfected BHK-21 cells and BHK-21 cells trans-
fected with pBRNX1.38, pBRNX1.38-5/6, or pBRNX1.38-
5/6-gfp RNA were seeded on glass coverslips and fixed
at different time points after electroporation with 3%
paraformaldehyde in PBS for 20 min at ambient temper-
ature. Before addition of the fixative, the cells were briefly
washed twice with PBS at room temperature. The para-
formaldehyde was inactivated by three 5-min washes
with PBS containing 10 mM glycine (PBS–Gly) and the
cells were permeabilized for 5 min with 0.5% Triton X-100
in PBS–Gly containing 5% FBS (PBS–Gly–FBS). Following
three 5-min washes with PBS–Gly–FBS, the cells were
incubated for 30 min at ambient temperature with the
EAV GL-specific MAb 74D(B) in hybridoma culture super-
atant. The cells were then stained with a Cy3-conju-
ated donkey anti-mouse IgG (H1L) antibody (Jackson
ImmunoResearch Laboratories), diluted 1:200 in PBS–
Gly–FBS. After a wash, the coverslips were briefly rinsed
in H2O and mounted on glass slides using a Mowiol
40-88 (Aldrich)-based mountant (Heimer and Taylor,
1974) containing 2.5% 1,4-diazobicyclo[2,2,2]octane as an
m
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275REPLICATION-COMPETENT EQUINE ARTERITIS VIRUS VECTORantibleaching agent. The samples were analyzed by la-
ser scanning confocal light microscopy using a Leica
TCS 4D system equipped with an appropriate set of
filters. Images were processed in Adobe PhotoShop ver-
sion 5.0 and printed on a Hewlett–Packard DeskJet 720C
printer.
Metabolic labeling, immunoprecipitation, and
fluorography
BHK-21 cells in 4-cm2 culture dishes were either mock
infected or infected with the parental or one of the re-
combinant viruses at a low (pBRNX1.38-5/6-gfp virus) or
intermediate (all other viruses) m.o.i. After a 30-min in-
cubation period in cysteine- and methionine-free me-
dium, the cells were metabolically labeled for 1 h at 24,
36, and 48 h postinfection in 300 ml of DMEM without
L-cystine, L-glutamine, and L-methionine (BioWhittaker)–2
M L-alanyl-L-glutamine–5% dialyzed FBS–10 mM
EPES (pH 7.4) supplemented with 4.5 ml of fresh Redi-
ue Pro-mix L-[35S] in vitro cell labeling mix (.1000 Ci/
mol; Amersham Pharmacia Biotech). Total lysates of
ells and media were then prepared by addition of 75 ml
of concentrated lysis buffer [100 mM Tris–HCl (pH 7.6),
150 mM NaCl, 5% Nonidet P-40, 2.5% sodium deoxy-
cholate, 0.5% SDS containing 5 mg of aprotinin, leupeptin,
nd pepstatin A per ml] directly to the labeling medium.
articulate material was removed from the lysates by
entrifugation for 30 min at 104 g and 4°C. The resulting
supernatants were adjusted to 5 mM EDTA and 100-ml
liquots of each protein sample were mixed with 900 ml
f immunoprecipitation buffer [20 mM Tris–HCl (pH 7.6),
50 mM NaCl, 5 mM EDTA, 0.5% Nonidet P-40, 0.1%
odium deoxycholate, 0.1% SDS supplemented with 1 mg
f the aforementioned protease inhibitors per ml] and
ncubated overnight at 4°C with 5 ml of a cocktail of
ntibodies directed against the EAV N, M, GL, and GS
proteins or with 1 ml of a GFP-specific antiserum. The
antibody cocktail was prepared by mixing 1 vol of the
EAV N-specific antiserum with 1 vol of ascites fluid con-
taining MAb 93B, 2 vol of the EAV M-specific antiserum,
and 6 vol of the antiserum directed against the EAV GS
protein. Immune complexes were collected with 75 ml of
formaldehyde-fixed and heat-inactivated Staphylococcus
aureus cells (Pansorbin cells; Calbiochem), washed as
previously described (de Vries et al., 1995), and analyzed
in an SDS–15% polyacrylamide gel. The gel was fixed in
10% acetic acid–50% methanol–0.005% Coomassie Bril-
liant Blue R250 at ambient temperature for 30 min,
soaked in 1 M sodium salicylate for the same period
(Chamberlain, 1979), dried on Whatman 3MM chroma-
tography paper, and exposed at 270°C to FujiRX film.
Molecular weight estimations were based on digital im-
ages of fluorographs obtained with a DC40 camera
(Eastman Kodak) and analyzed using Kodak Digital Sci-
ence 1D image analysis software version 1.6.ACKNOWLEDGMENTS
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